Disc Medicine (IRON) Total Non-Current Liabilities (2020 - 2023)

Disc Medicine's (IRON) quarterly Total Non-Current Liabilities came in at $16.0 million in Q3 2023, up 994.47% year-on-year from $1.5 million in Q3 2022, and up 39.88% on a QoQ basis from $11.5 million in Q2 2023.

Disc Medicine (IRON) Total Non-Current Liabilities (2020 - 2023) Analysis & Trends

Disc Medicine (IRON) has 4 years of Total Non-Current Liabilities data on file, last reported at $16.0 million in Q3 2023.

  • On a quarterly basis, Total Non-Current Liabilities rose 994.47% year-over-year to $16.0 million in Q3 2023; TTM through Sep 2023 was $16.0 million, a 994.47% increase from a year earlier, with the FY2022 full-year figure at $23.6 million, up 76.71% from the prior year.
  • Total Non-Current Liabilities for Q3 2023 stood at $16.0 million, up from $11.5 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for IRON reached as high as $29.9 million in Q4 2020 and fell as low as -$66000.0 in Q1 2020.
  • Historically, Total Non-Current Liabilities has averaged $12.4 million across 4 years, with a median of $13.4 million in 2021.
  • Across the five-year window, Total Non-Current Liabilities jumped 27228.79% in 2021 and sank 90.02% in 2022, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $29.9 million in 2020, then tumbled by 55.33% to $13.4 million in 2021, then soared by 76.71% to $23.6 million in 2022, then plunged by 32.12% to $16.0 million in 2023.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $16.0 million in Q3 2023, $11.5 million in Q2 2023, and $23.6 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 4.45 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 110.28 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 19.49 Mn
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.98 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 5.87 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 7.32 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 40.00 Mn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 746.94 Mn
10 Disc Medicine 2.89 Bn 2.89 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2023 16.02 Mn
Jun 30, 2023 11.46 Mn
Dec 31, 2022 23.61 Mn
Sep 30, 2022 1.46 Mn
Jun 30, 2022 6.44 Mn
Mar 31, 2022 12.67 Mn
Dec 31, 2021 13.36 Mn
Sep 30, 2021 14.67 Mn
Jun 30, 2021 14.39 Mn
Mar 31, 2021 17.91 Mn
Dec 31, 2020 29.90 Mn
Jun 30, 2020 -66,000.00
Mar 31, 2020 -66,000.00